Case Study: A Global Biotech Company Achieves 95% Patient Adherence with Axtria DataMAx

Global Biotech Company boosts patient adherence to 95% with Axtria

The global biotech company faced a challenge in harnessing the potential of its complex and fragmented patient-level data across geographies. Without sophisticated data management, it was unable to effectively track patient journeys or influence therapy-adherence patterns. To address this, the company partnered with vendor Axtria, which utilized its Axtria DataMAx™ platform.

Axtria implemented a solution by streamlining the data into a unified, HIPAA-compliant data hub. This enabled rapid patient analytics, reducing the time to gain insights from six months to a weekly basis. The effort resulted in a 95% patient adherence rate, significantly improving health outcomes and earning the client industry-wide recognition.